Alerts

Bliss Baby is recalling all batches of ARTG 351147 - Flatus tube, single-use - Lufti Colic Reliever, due to insufficient evidence provided to the TGA to support its safe use.

Stryker is conducting an urgent product correction of certain lots of the HeartSine Defibrillator. Stryker is now attempting to reach the small percentage of customers affected.

Stryker is conducting an urgent recall of certain lots of the HeartSine Samaritan Public Access Defibrillator Pak (PAD-PAK). Stryker is now attempting to reach the small percentage of customers affected.

Ritalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.

Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.

Takeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.

Magnum XXL capsules pose a serious risk to your health and should not be taken.

Several vitamin and perinatal (including preconception) products are being recalled due to a lack of or excessive levels of potassium iodine.

More prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.

Possible risk of learning, communication and behaviour problems in children born to men taking this medicine.

Boston Scientific have advised that subsets of ACCOLADE and VISIONIST pacemakers have an increased risk of permanently entering Safety Mode which has limited functionality.

The supply of Ozempic (semaglutide) will continue to be limited until 31 December 2025

Pharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.

Caruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.

Dynamint X tablets pose a serious risk to your health and should not be taken.

MAXMAN tablets pose a serious risk to your health and should not be taken.

There is a potential for insulin leakage with the Accu-Chek Spirit 3.15 ml cartridge system due to a manufacturing problem.

Due to the concerns and difficulties caused by such shortages, we are giving patients and prescribers early notification so that they can plan ahead.

Pharmacists may dispense alternative brands or strengths without a new prescription.

The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.

African Vigorous Max Strength poses a serious risk to your health and should not be taken.

We have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.

Ziyinzhuangyang tablets pose a serious risk to your health and should not be taken.

Consumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.

We have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.